Foamix Pharmaceuticals Ltd. Operating Lease, Expense
Foamix Pharmaceuticals Ltd. reported Operating Lease, Expense of $872.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. operating lease, expense for fiscal 2018 was $872.00K, a 30.73% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. operating lease, expense for fiscal 2017 was $667.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2018-12-31 | $872.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $667.00K 10-K · filed 2020-03-12 |